Literature DB >> 5076768

Studies on human triosephosphate isomerase. II. Nature of the electrophoretic multiplicity in erythrocytes.

T H Sawyer, B E Tilley, R W Gracy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5076768

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  7 in total

Review 1.  Advances in hereditary red cell enzyme anomalies.

Authors:  A Kahn; J C Kaplan; J C Dreyfus
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: equations and parameter refinement.

Authors:  P J Mulquiney; P W Kuchel
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

3.  Studies on human triosephosphate isomerase. 3. Characterization of the enzyme from patients with the cri du chat syndrome.

Authors:  R J Hendrickson; R M Snapka; T H Sawyer; R W Gracy
Journal:  Am J Hum Genet       Date:  1973-07       Impact factor: 11.025

4.  Characterization of two new electrophoretic variants of human triosephosphate isomerase: stability, kinetic, and immunological properties.

Authors:  J Asakawa; H W Mohrenweiser
Journal:  Biochem Genet       Date:  1982-02       Impact factor: 1.890

5.  Origin of the triosephosphate isomerase isozymes in humans: genetic evidence for the expression of a single structural locus.

Authors:  R S Decker; H W Mohrenweiser
Journal:  Am J Hum Genet       Date:  1981-09       Impact factor: 11.025

6.  Structural evidence that human liver and placental alkaline phosphatase isoenzymes are coded by different genes.

Authors:  K S Badger; H H Sussman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

7.  Triose phosphate isomerase deficiency is caused by altered dimerization--not catalytic inactivity--of the mutant enzymes.

Authors:  Markus Ralser; Gino Heeren; Michael Breitenbach; Hans Lehrach; Sylvia Krobitsch
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.